Henry Schein (HSIC) EBITDA Margin (2009 - 2026)
Henry Schein (HSIC) recorded quarterly EBITDA Margin of 5.4% in Q1 2026, up 13.94% quarter-over-quarter from 4.74% in Q4 2025, and down 12.0% on a YoY basis from 6.14% in Q1 2025.
Henry Schein (HSIC) EBITDA Margin (2009 - 2026) Analysis & Trends
Henry Schein's EBITDA Margin history runs 18 years deep, the most recent figure standing at 5.4% for Q1 2026.
- In Q1 2026, EBITDA Margin fell 12.0% year-over-year to 5.4%; the TTM figure through Mar 2026 stood at 4.93% (down 17.0% YoY), while the FY2025 annual figure was 5.72%, up 16.0% from the prior year.
- EBITDA Margin was 5.4% for Q1 2026 at Henry Schein, up from 4.74% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 7.68% in Q1 2022 to a low of 1.29% in Q4 2023.
- Historically, EBITDA Margin has averaged 5.21% across 5 years, with a median of 5.07% in 2024.
- The sharpest annual moves came in 2022 and 2024: EBITDA Margin slumped 390 bps in 2022, then surged 356 bps in 2024.
- A 5-year view of EBITDA Margin shows it stood at 2.14% in 2022, then plunged by 39 bps to 1.29% in 2023, then surged by 276 bps to 4.86% in 2024, then decreased by 2 bps to 4.74% in 2025, then gained by 14 bps to 5.4% in 2026.
- The last three EBITDA Margin figures came in at 5.4% (Q1 2026), 4.74% (Q4 2025), and 4.91% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 2.23% |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 1.63% |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | 0.84% |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 5.40% |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | 7.33% |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | -41.35% |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | -0.59% |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | -17.29% |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 5.40% |
| Dec 27, 2025 | 4.74% |
| Sep 27, 2025 | 4.91% |
| Jun 28, 2025 | 4.66% |
| Mar 29, 2025 | 5.52% |
| Dec 28, 2024 | 4.86% |
| Sep 28, 2024 | 4.95% |
| Jun 29, 2024 | 5.07% |
| Mar 30, 2024 | 4.73% |
| Dec 30, 2023 | 1.29% |
| Sep 30, 2023 | 6.33% |
| Jul 1, 2023 | 6.48% |
| Apr 1, 2023 | 5.72% |
| Dec 31, 2022 | 2.14% |
| Sep 24, 2022 | 6.88% |
| Jun 25, 2022 | 7.26% |
| Mar 26, 2022 | 7.68% |
| Dec 25, 2021 | 6.03% |
| Sep 25, 2021 | 6.64% |
| Jun 26, 2021 | 7.08% |